Has Troy Ellis, MD received payments from drug or device companies?

Yes. Drug and device makers reported $14,179 in general payments to Troy Ellis, MD across 564 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Troy Ellis, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Troy Ellis, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Troy Ellis, MD

Dermatology · Peoria, AZNPI 1356491997

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 93.8% of the total across 564 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 19.4% — the pattern of someone who eats at a lot of different presentations.

$14,179in general payments, 2019–2025

Across 564 payments — averaging $25.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$3K
Abbott$2K
Johnson & Johnson$904
Sun Pharmaceutical Industries Inc.$765
Amgen$744
UCB, Inc.$731
plus $6K from 27 others

What the payments were for

Speaking & faculty fees$7085%
Food & beverage$13,30194%
Education$1701%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	93	$2,744
Abbott	63	$2,088
Johnson & Johnson	42	$904
Sun Pharmaceutical Industries Inc.	28	$765
Amgen	30	$744
UCB, Inc.	20	$731
Regeneron Healthcare Solutions, Inc.	26	$714
Dermavant Sciences, Inc.	41	$657
Biofrontera Inc.	3	$642
LEO Pharma Inc.	34	$591
E.r. Squibb & Sons, L.L.C.	13	$435
Ortho Dermatologics, A Division Of Bausch Health US, LLC	33	$407
Lilly USA, LLC	20	$398
Pfizer	16	$378
Sanofi	13	$308
Genentech USA, Inc.	13	$280
Galderma Laboratories, L.p.	15	$234
Incyte Corporation	12	$230
Almirall LLC	9	$180
Arcutis Biotherapeutics, Inc.	8	$152
Medtronic	1	$98
Mayne Pharma Commercial LLC	7	$76
Organon	5	$65
Helsinn Therapeutics (U.S.), Inc.	4	$62
Novartis	2	$56
Bristol Myers Squibb	4	$49
Organogenesis Inc.	2	$43
Kyowa Kirin, Inc.	2	$42
EPI Health, LLC	1	$27
Surgenex LLC	1	$23
Journey Medical Corporation	1	$23
Boehringer Ingelheim	1	$16
Dermira, Inc.	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,179 in reported general payments places this provider in the 85th percentile of 305 dermatology providers in Arizona.

See all dermatology providers in Arizona →

Medicare billing

Part B allowed, 2024

$428,424

Medicare patients

1,262

Services billed

6,335

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Dupixent PenDupilumab	11	$40,851
Clobetasol Propionate	235	$7,873
Fluorouracil	94	$6,641
Doxycycline Hyclate	45	$2,209
Metronidazole	25	$1,695
Acitretin	14	$1,649
Fluocinonide	38	$1,457
Ketoconazole	91	$1,363
Triamcinolone Acetonide	162	$1,147
Hydroxychloroquine Sulfate	11	$869
Hydrocortisone	79	$500
Mometasone Furoate	18	$339
Doxycycline Monohydrate	21	$312
Clotrimazole	12	$219
Mupirocin	12	$96

Paid to pharmacies, not to this prescriber.

Other dermatology in Peoria

Dane HillPeoria$13K
Julie JacobsPeoria$8K
Mary FredenbergPeoria$8K
Lindsay AckermanPhoenix$1.6M
Kathleen ObrienTucson$742K
Nathalie ZeitouniPhoenix$584K
John KastelerGilbert$456K
Anthony NuaraScottsdale$432K
Carsten HamannPhoenix$364K
James SlighTucson$238K

See the full list for Arizona →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →